Elaine tells of the seemingly insurmountable hurdles of the forces that she has encountered while trying to bring a treatment option into mainstream medicine. She has been met with great resistance from the NMSS and some pharmaceutical companies. Is the resistance because Prokarin threatens the cash cow? Read and decide for yourself.
Disclaimer
The opinions, recommendations and contributed articles contained on this website are not necessarily those of EDMS, LLC or endorsed by EDMS, LLC. Further, nothing on this website is intended to offer medical advice for the treatment of illness or disease. Specific questions pertaining to the reader's medical condition and appropriate care should be directed to the reader’s physician or other health care professional. The information on this web site has not been viewed or approved by the FDA.
